Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Synta Pharmaceuticals prepares new IL-2/CRAC-targeted products

June 13, 2012

New PI3K inhibitors developed in U.S.

June 13, 2012

Merck & Co. reports new CGRP receptor antagonists

June 13, 2012

Novel diagnostics disclosed by Janssen Pharmaceuticals

June 13, 2012

Bristol-Myers Squibb patents novel inhibitors of CYP17

June 13, 2012

Roche presents novel LRRK2 inhibitors

June 13, 2012

New ENTPD5 inhibitors developed by University of Texas System

June 12, 2012

Gedeon Richter patents novel bradykinin B1 receptor antagonists

June 12, 2012

Bristol-Myers Squibb reports preparation of novel mGlu5 receptor modulators

June 12, 2012

Daiichi Sankyo presents new diacylglycerol O-acyltransferase inhibitors

June 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.